Sign in

CIK 0001750149 · Non-accelerated filer<br>Smaller reporting company

Inhibikase Therapeutics, Inc.

Sign in to watch
Ticker
IKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
263407249
Phone
(302) 295-3800
Business address
1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. 8-K Event Other events
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. EFFECT Other Notice of Effectiveness
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. UPLOAD Other SEC-generated Letter
  11. S-3 Offering Registration Statement
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  17. EFFECT Other Notice of Effectiveness
  18. 8-K Event Agreement ended
  19. 424B3 Offering Prospectus
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 7 of 19 · 370 filings